65,437 trials
Total Knee Replacement · Total Hip Replacement
Primary: Pain Measured by the Numeric Rating Scale — 3.34; 3.32 units on a scale
Gram Negative Infections
Primary: Number of Participants With Clinical Symptom Improvement at Day 3 — 82; 21 Participants
RAD
Primary: Radiation Readings — 122.8; 158.8; 236.9 mREM
Parkinson Disease
Primary: Change in Composite Score on Self-efficacy Scale — 38.5; 43 score on a scale
Fluid Loss
Primary: Change in the Relative Index (RI) After Minor Blood Loss (e.g., 500mL) — 2.9 Percent change in RI
Metastatic Breast Cancer
Primary: Number of Participants Reporting Treatment-emergent Adverse Events (TEAEs) — 3; 3; 15; 15 Participants
Post-Traumatic Stress Disorder
Primary: Post-traumatic Stress Disorder Checklist for DSM-5 (PCL-5) Total Score — 48.6; 45.0; 38.5; 41.3 score on a scale
Overweight and Obesity · Adiposity · Nutrient; Excess
Primary: Change in Mother's Height From Baseline (Time 1) to Time 2 — -0.00977; 0.000505 Centimeters
Depression
Primary: Usage Rates — 47 participants
Effects of Family History of Alcoholism and Sex on Alcohol Analgesia
Primary: Heat Pain Threshold — 43.56; 43.63; 42.28; 43.94 degrees celsius — p=.92
Retinitis Pigmentosa
Primary: The Primary Outcome is the Change in Best-corrected Visual Acuity (BCVA) Using the Electronic Visual Acuity (EVA) Technology at Month 12. — 1; 1; 3; 1 participants
Appendicitis · Appendicitis; Perforation
Primary: Length of Hospital Stay — 121.55; 131.69 hours
Obesity
Primary: Percentage Change in Body Weight — -14.2; -2.5 Percentage change in body weight — p=<0.0001
Bacterial Vaginosis · HIV Infections
Primary: Number of Participants With Genital Tract Inflammation — 3; 2 Participants
Pharmacokinetics
Primary: Mean PRKACA Change — 7224.56; 5348.93; 6307.21; 6495.7 relative fluorescence units